OneCell Diagnostics today announced its launch of OncoIncytes, a comprehensive multi-modal cancer diagnostic panel that integrates multiple types of data including Circulating Tumor DNA (ctDNA), ...

WellSky, a global health and community care technology and services company, today announced its latest innovations in Artificial Intelligence (AI). The company's SkySense AI-powered tools and ...

GenAI offers a realistic path forward in tackling previously undruggable targets, with the potential to reshape the entire ...

Despite issues with data quality and privacy, the use of AI in drug discovery has enormous potential to revolutionize the pharmaceutical sector by providing quicker, more accurate, and more ...

Elix Inc. has entered into a drug discovery collaboration with Prism Biolab Co. Ltd. to accelerate AI-driven drug discovery for challenging protein-protein interaction targets. The partnership will ...

Explore how large language models enhance knowledge graphs in drug discovery and improve data management and reasoning.

Drug discovery firm Exscientia has claimed a world first after announcing that the first precision engineered drug generated by artificial intelligence (AI) is entering clinical trials.

Interested in finding a better way to develop drugs to treat amyotrophic lateral sclerosis (ALS), Northeastern researcher ...

Simulations Plus, Inc. offers AI-based software tools for drug discovery and optimization, significantly reducing R&D time and costs for pharmaceutical research. SLP's diverse software portfolio ...

The deal represents a continued push by Lilly to expand its use of AI in drug discovery and development. In 2023, the company partnered with OpenAI to identify new antimicrobials targeting drug ...